Unique ID issued by UMIN | UMIN000023489 |
---|---|
Receipt number | R000027055 |
Scientific Title | Comparative evaluation of thienopyridines on platelet aggregation in patients with ischemic heart disease in multi-centers in Okinawa |
Date of disclosure of the study information | 2016/08/31 |
Last modified on | 2021/01/28 16:56:07 |
Comparative evaluation of thienopyridines on platelet
aggregation in patients with ischemic heart disease in multi-centers in Okinawa
CHIMU Okinawa Study
Comparative evaluation of thienopyridines on platelet
aggregation in patients with ischemic heart disease in multi-centers in Okinawa
CHIMU Okinawa Study
Japan |
coronary heart disease
Cardiology |
Others
YES
The purpose of this study is to compare with the platelet aggregation ability by clopidogrel maintenance dose remedy and the platelet aggregation ability after the change in prasugrel and to evaluate the safety of switching from clopidogrel to prasugrel and participation of CYP2C19.
Safety,Efficacy
Not applicable
Platelet aggregation ability (PRU in VerifyNow) at the time of clopidogrel remedy and the prasugrel remedy
Complications including a cardiovascular event and the bleeding until one year later.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Medicine |
continuation group of the maintenance dose by the clopidogrel(75mg/day)
It is change group from clopidogrel of the maintenance dose in prasugrel(3.75mg./day) of the maintenance dose
20 | years-old | <= |
85 | years-old | > |
Male and Female
The chronic coronary disease patient who is taking clopidogrel for more than one month.
1)Dialysis
2)Dangerously ill liver disease patient
3)Malignant tumor of the activity
4)The patient that art of planned coronary revasculalization is not completed
5)PCI enforcement patients within 7 days
6)Dangerously ill heart failure patient(LVEFless than 30%. NYHA IV)
7)More than less than 50,000 number of the platelets /micro l or 500,000 /micro l, it is less than 30% of hematocrit or more than 50%
8)Bleeding patient
9)Patients who need treatment with anticoagulant
10)The patient who is participating in other clinical trials
11)Pregnant patient
12)the patient who judged that the medical attendant was inappropriate
160
1st name | |
Middle name | |
Last name | Masashi Iwabuchi |
Graduate School of Medicine, University of Ryukyus
Department of Cardiovascular Medicine, Nephrology and Neurology
207 Uehara, Nishihara-cho, Okinawa, Japan
098-895-1150
msiwabuchi@yahoo.co.jp
1st name | |
Middle name | |
Last name | Masashi Iwabuchi |
Graduate School of Medicine, University of Ryukyus
Department of Cardiovascular Medicine, Nephrology and Neurology
207 Uehara, Nishihara-cho, Okinawa, Japan
098-895-1150
3naika-crc@w3.u-ryukyu.ac.jp
Graduate School of Medicine, University of Ryukyus
Department of Cardiovascular Medicine, Nephrology and Neurology
DAIICHI SANKYO co.,LTD.
Other
NO
琉球大学附属病院(沖縄県)、沖縄県立中部病院(沖縄県)、浦添総合病院(沖縄県)、那覇市立病院(沖縄県)、大浜第一病院(沖縄県)、豊見城中央病院(沖縄県)
2016 | Year | 08 | Month | 31 | Day |
Unpublished
Completed
2015 | Year | 12 | Month | 07 | Day |
2015 | Year | 12 | Month | 07 | Day |
2016 | Year | 12 | Month | 01 | Day |
2019 | Year | 01 | Month | 31 | Day |
2019 | Year | 06 | Month | 03 | Day |
2019 | Year | 06 | Month | 16 | Day |
2019 | Year | 11 | Month | 15 | Day |
2016 | Year | 08 | Month | 04 | Day |
2021 | Year | 01 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027055